tiprankstipranks
Xenon (XENE)
NASDAQ:XENE
US Market
XENE
Xenon
RESEARCH TOOLSreports

Xenon (XENE) Stock News & Sentiment

447 Followers
Xenon to Unveil Phase 3 Azetukalner Data and Pipeline Advances at 2026 AAN Meeting
Premium
Company Announcements
Xenon to Unveil Phase 3 Azetukalner Data and Pipeline Advances at 2026 AAN Meeting
3d ago
XENE
Xenon Sets Date for 2026 Annual Shareholder Meeting
Premium
Company Announcements
Xenon Sets Date for 2026 Annual Shareholder Meeting
28d ago
8K
XENE
Xenon’s X-TOLE2 Trial Completion Puts XEN1101 in Focus for Epilepsy Investors
Premium
Company Announcements
Xenon’s X-TOLE2 Trial Completion Puts XEN1101 in Focus for Epilepsy Investors
28d ago
XENE
Xenon Strengthens Balance Sheet With Major Equity Offering
Premium
Company Announcements
Xenon Strengthens Balance Sheet With Major Equity Offering
29d ago
8K
XENE
Xenon Raises $650 Million in Upsized U.S. Equity Offering
Premium
Company Announcements
Xenon Raises $650 Million in Upsized U.S. Equity Offering
1M ago
XENE
Xenon Pharmaceuticals: Buy Rating Backed by Superior X-TOLE2 Phase 3 Results and Commercial Upside for Azetukalner in Focal Epilepsy
Premium
Ratings
Xenon Pharmaceuticals: Buy Rating Backed by Superior X-TOLE2 Phase 3 Results and Commercial Upside for Azetukalner in Focal Epilepsy
1M ago
XENE
Xenon Pharmaceuticals Launches $500 Million Public Share Offering
Premium
Company Announcements
Xenon Pharmaceuticals Launches $500 Million Public Share Offering
1M ago
XENE
More XENE News >

XENE News on the Web

Xenon to Unveil Phase 3 Azetukalner Data and Pipeline Advances at 2026 AAN Meeting
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Intensity Therapeutics, Inc. (INTS), IQVIA Holdings (IQV) and Xenon (XENE)
TipRanks News
Neutral
COMMODORE CAPITAL LP's Strategic Acquisition of AN2 Therapeutics Inc Shares
GuruFocus News
Neutral
Xenon Pharmaceuticals Stock Soars 20% in 3 Months: Here's Why
Zacks
Bullish
COMMODORE CAPITAL LP Acquires Additional Shares in PepGen Inc
GuruFocus News
Neutral
Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Protagonist Therapeutics (PTGX) and CG Oncology, Inc. (CGON)
TipRanks News
Neutral
Xenon Pharmaceuticals price target lowered to $63 from $64 at Wedbush
TipRanks News
Neutral
H.C. Wainwright Keeps Their Buy Rating on Xenon (XENE)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
XENE
Sector Average
Media Buzz
This Week1 articles
Weekly Average2 articles
News Sentiment
This Week50%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is XENE’s Media Buzz Sentiment?
1 articles about XENE were published this week. In an average week, 2 articles are published.
    What is XENE’s weekly average amount of articles?
    In an average week, 2 articles about XENE are published.
      What is XENE’s News Sentiment?
      50% of articles about XENE were positive this week, compared to its sector average of 69%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        OWLTOwlet
        IVVDInvivyd
        Showing the stocks with the most bullish news sentiment over the past week